VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER2−/PIK3CA Wild-Type Advanced Breast CancerSara A. Hurvitz, Amanda Gillespie-Twardy, Rachel M. Layman et al.|Journal of Clinical Oncology|2026Cited by 4
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database AnalysisPablo Mandó, G. Colucci, Rodrigo Sánchez-Bayona et al.|JCO Global Oncology|2024Cited by 0